蜜桃视频

蜜桃视频 Therapeutics is developing the first platform for creating programmable, long-acting mRNA therapeutics capable of delivering precise, multi-functional, potentially curative treatments. Welcome to the future of biology, today.聽

#image_title

The first autonomous medicines

蜜桃视频 is applying its proprietary technology and world-class expertise to create autonomous medicines that unlock the true potential of mRNA medicines by dramatically increasing the therapeutic window.聽 蜜桃视频 does this by selecting the right type of mRNA for the job and then programming logic-based circuits into the mRNA to enable it to sense different cell types and only activate in the diseased cells.聽聽This means mRNA can travel anywhere in the body but its therapeutic聽protein payload is allowed to act in only the appropriate locations. 蜜桃视频鈥檚 genetic circuits allow us to turn off the mRNA when it lands in healthy cells.

The real deal in synthetic bio

蜜桃视频 was co-founded by world-leading mRNA researchers from the MIT Synthetic Biology Center.

Programmable pipeline

蜜桃视频 has developed the first programming language for mRNA. 蜜桃视频 embeds mRNA therapeutics with sophisticated logic to enable them to identify which cell types they are in and then follow a programmed course of action.聽

Our team is developing a pipeline of programmable, long-acting mRNA therapeutics that are bioengineered to enable precise control of the location, timing, intensity, and duration of protein expression. With the company鈥檚 self-replicating mRNAs, 蜜桃视频鈥檚 goal is to develop improved treatment options for cancer and other life-threatening diseases.

Partnerships

Our mission is to transform the lives of patients through the development of highly targeted, potentially curative programmable mRNA therapeutics. We are open to exploring opportunities to expand our programs.

Media

Join our team

蜜桃视频 is building a team that understands the value of working at an emerging biotech. Joining the company now means having vast opportunities to learn and grow, including exposure to all aspects of building a company.

Awards